日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia

MLL-TFE3:一种在婴儿白血病中发现的新型且具有侵袭性的KMT2A融合基因

Kosasih, Hansen J; Davidson, Nadia M; Bjelosevic, Stefan; Morrish, Emma; Brennan, Margs S; Oshlack, Alicia; Johnstone, Ricky W; Brumatti, Gabriela; Khaw, Seong L; Ekert, Paul G

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

临床 MDR1 抑制剂可增强 Smac 模拟物的生物利用度,从而杀死小鼠 LSC 并提高 AML 模型中的生存率

Morrish Emma, Copeland Anthony, Moujalled Donia M, Powell Jason A, Silke Natasha, Lin Ann, Jarman Kate E, Sandow Jarrod J, Ebert Gregor, Mackiewicz Liana, Beach Jessica A, Christie Elizabeth L, Lewis Alexander C, Pomilio Giovanna, Fischer Karla C, MacPherson Laura, Bowtell David D L, Webb Andrew I, Pellegrini Marc, Dawson Mark A, Pitson Stuart M, Wei Andrew H, Silke John, Brumatti Gabriela